StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) stock

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.74−0.19 (-9.84%)

Close on Nov 17, 2026Market cap $21.83MP/E –Yield –

Incannex Healthcare ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Incannex Healthcare's ebitda for the twelve months ending Sep 30, 2026 was -$19.49M. For fiscal 2026 it was -$22.79M.

Annual ebitda

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$22.79M–
FY2025Jun 30, 2025-$23.54M–
FY2024Jun 30, 2024-$29.94M–
FY2023Jun 30, 2023-$49.58M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$3.43M–
Q4 FY2026CQ2 2026Jun 30, 2026-$5.14M–
Q3 FY2026CQ1 2026Mar 31, 2026-$3.98M–
Q2 FY2026CQ4 2025Dec 31, 2025-$6.94M–
Q1 FY2026CQ3 2025Sep 30, 2025-$6.73M–
Q4 FY2025CQ2 2025Jun 30, 2025-$7.47M–
Q3 FY2025CQ1 2025Mar 31, 2025-$5.01M–
Q2 FY2025CQ4 2024Dec 31, 2024-$4.88M–
Q1 FY2025CQ3 2024Sep 30, 2024-$6.19M–
Q4 FY2024CQ2 2024Jun 30, 2024-$9.68M–
Q3 FY2024CQ1 2024Mar 31, 2024-$7.40M–
Q2 FY2024CQ4 2023Dec 31, 2023-$7.97M–
Q1 FY2024CQ3 2023Sep 30, 2023-$4.88M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.13M–
Q3 FY2023CQ1 2023Mar 31, 2023-$3.66M–

More Incannex Healthcare figures

See a number that looks wrong?